BioSpace News Archive

Next generation digital health module uniquely designed to keep patients on home dialysis by helping identify potential therapy complications Sharesource Analytics will further enhance healthcare professionals’ ability to keep peritoneal dialysis patients safer at home during the COVID-19 pandemic

Jaguar Health, Inc. (NASDAQ:JAGX) issued a reminder today that an Innovators with Jane King webcast interview with Jaguar CEO Lisa Conte & Dragon SPAC S.p.A. founding sponsor Josh Mailman will air this Thursday, June 3, 2021, at 8:30 AM Eastern Time.

ResMed announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginning at approximately 1:20 p.m.

STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of Cantel Medical, a global provider of infection prevention products and services to endoscopy, dental, dialysis and life sciences Customers.

NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of precision genetic medicines, today announced that it will host a virtual R&D day for investors and analysts on Tuesday, June 8, 2021 at 12:30 p.m. EDT.

This summer is blasting off with the FedEx St. Jude Angels & Stars Giving Campaign for St. Jude Children’s Research Hospital® from now through June 30, with an online auction going live on June 10.

ObvioHealth, a global Virtual Research Organization (VRO), announces a new partnership with Hyfe AI, an artificial intelligence company with a tool to detect and track acoustic signatures, with an initial focus on coughing

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by Takeda to be a specialty pharmacy partner for ALUNBRIG® (brigatinib), an oral therapy option for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).

Novartis today announced robust data from the primary analysis of the pivotal Phase II ELARA trial of Kymriah® (tisagenlecleucel) in patients with relapsed or refractory (r/r) follicular lymphoma (FL)1.

DiFusion Technologies, Inc. today announced landmark data for the company’s ZFUZE Surgical Polymer and how it compares to traditional biomaterials like Titanium and Poly-Ether-Ether-Ketone (PEEK). The data and the importance of the immune system response in new technologies such as ZFUZE were debated at the International Society for Advancement of Spine Surgery – ISASS in late May in Miami.